Search Results - "Marlowe, Robert J."

Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies by Coerts, Hannelore I, de Keizer, Bart, Marlowe, Robert J, Verburg, Frederik A

“…For patients undergoing radioiodine therapy (RIT) of differentiated thyroid carcinoma (DTC), thyroid-stimulating hormone (TSH) stimulation prior to RIT can be…”
Get full text

Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT by Rosar, Florian, Burgard, Caroline, David, Scott, Marlowe, Robert J., Bartholomä, Mark, Maus, Stephan, Petto, Sven, Khreish, Fadi, Schaefer-Schuler, Andrea, Ezziddin, Samer

“…Candidates for prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) of metastatic castration-resistant prostate cancer (mCRPC)…”
Get full text

Outstanding increase in tumor-to-background ratio over time allows tumor localization by [ 89 Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer by Burgard, Caroline, Rosar, Florian, Larsen, Elena, Khreish, Fadi, Linxweiler, Johannes, Marlowe, Robert J, Schaefer-Schuler, Andrea, Maus, Stephan, Petto, Sven, Bartholomä, Mark, Ezziddin, Samer

“…Positron emission tomography/computed tomography (PET/CT) using prostate-specific membrane antigen (PSMA)-targeted radiotracers labeled with zirconium-89 ( Zr;…”
Get full text

[ 89 Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [ 68 Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis by Rosar, Florian, Burgard, Caroline, Larsen, Elena, Khreish, Fadi, Marlowe, Robert J, Schaefer-Schuler, Andrea, Maus, Stephan, Petto, Sven, Bartholomä, Mark, Ezziddin, Samer

“…The state-of-the-art method for imaging men with biochemical recurrence of prostate cancer (BCR) is prostate-specific membrane antigen (PSMA)-targeted positron…”
Get full text

177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study) by Khreish, Fadi, Ghazal, Zaidoon, Marlowe, Robert J., Rosar, Florian, Sabet, Amir, Maus, Stephan, Linxweiler, Johannes, Bartholomä, Mark, Ezziddin, Samer

“…Purpose Preliminary data from retrospective analyses and recent data from large randomized controlled trials suggest safety and efficacy of radioligand therapy…”
Get full text

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer by Rosar, Florian, Khreish, Fadi, Marlowe, Robert J., Schaefer-Schuler, Andrea, Burgard, Caroline, Maus, Stephan, Petto, Sven, Bartholomä, Mark, Ezziddin, Samer

“…Rationale In patients with biochemical recurrence of prostate cancer (BCR), preliminary data suggest that prostate-specific membrane antigen (PSMA) ligand…”
Get full text

Screening for idiopathic pulmonary fibrosis using comorbidity signatures in electronic health records by Onishchenko, Dmytro, Marlowe, Robert J., Ngufor, Che G., Faust, Louis J., Limper, Andrew H., Hunninghake, Gary M., Martinez, Fernando J., Chattopadhyay, Ishanu

“…Idiopathic pulmonary fibrosis (IPF) is a lethal fibrosing interstitial lung disease with a mean survival time of less than 5 years. Nonspecific presentation, a…”
Get full text

The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review by Schuetz, Philipp, Marlowe, Robert J, Mueller, Beat

“…Plasma proadrenomedullin (ProADM) is a blood biomarker that may aid in multidimensional risk assessment of patients with chronic obstructive pulmonary disease…”
Get more information

Detection Efficacy of 68Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience by Burgard, Caroline, Hoffmann, Manuela A., Frei, Madita, Buchholz, Hans-Georg, Khreish, Fadi, Marlowe, Robert J., Schreckenberger, Mathias, Ezziddin, Samer, Rosar, Florian

“…In biochemical recurrence of prostate cancer (BCR), prompt tumor localization guides early treatment, potentially improving patient outcomes. Gallium-68…”
Get full text

Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence by Reinecke, Maximilian J., Ahlers, Gerrit, Burchert, Andreas, Eilsberger, Friederike, Flux, Glenn D., Marlowe, Robert J., Mueller, Hans-Helge, Reiners, Christoph, Rohde, Fenja, van Santen, Hanneke M., Luster, Markus

“…Purpose Concern is growing about long-term side effects of differentiated thyroid cancer treatment, most notably radioactive iodine (RAI) therapy. However,…”
Get full text

Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations by Burgard, Caroline, Rosar, Florian, Marlowe, Robert J, Bartholomä, Mark, Dewes, Sebastian, Schaefer-Schuler, Andrea, Linxweiler, Johannes, Khreish, Fadi, Ezziddin, Samer

“…"Tumor sink effects", decreased physiological uptake of radiopharmaceuticals due to sequestration by a tumor, may impact radioligand therapy (RLT) toxicity and…”
Get full text

Detection Efficacy of [sup.68]Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience by Burgard, Caroline, Hoffmann, Manuela A, Frei, Madita, Buchholz, Hans-Georg, Khreish, Fadi, Marlowe, Robert J, Schreckenberger, Mathias, Ezziddin, Samer, Rosar, Florian

“…Men with biochemical recurrence of prostate cancer (BCR) have increasing prostate-specific antigen (PSA) levels after potentially curative treatment, e.g.,…”
Get full text

Twenty-Five Years After Chernobyl: Outcome of Radioiodine Treatment in Children and Adolescents With Very High-Risk Radiation-Induced Differentiated Thyroid Carcinoma by Reiners, Christoph, Biko, Johannes, Haenscheid, Heribert, Hebestreit, Helge, Kirinjuk, Stalina, Baranowski, Oleg, Marlowe, Robert J, Demidchik, Ewgeni, Drozd, Valentina, Demidchik, Yuri

“…Context: After severe reactor emergencies with release of radioactive iodine, elevated thyroid cancer risk in children and adolescents is considered the main…”
Get full text

Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: Results from the randomized ProHOSP trial by Schuetz, Philipp, Kutz, Alexander, Grolimund, Eva, Haubitz, Sebastian, Demann, Désirée, Vögeli, Alaadin, Hitz, Fabienne, Christ-Crain, Mirjam, Thomann, Robert, Falconnier, Claudine, Hoess, Claus, Henzen, Christoph, Marlowe, Robert J, Zimmerli, Werner, Mueller, Beat

“…Abstract Background/objectives We sought to determine whether exclusion of infection and antibiotic stewardship with the infection biomarker procalcitonin…”
Get full text

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer by Pitoia, Fabián, Marlowe, Robert J., Abelleira, Erika, Faure, Eduardo N., Bueno, Fernanda, Schwarzstein, Diego, Lutfi, Rubén Julio, Niepomniszcze, Hugo

“…To supplement limited relevant literature, we retrospectively compared ablation and disease outcomes in high-risk differentiated thyroid carcinoma (DTC)…”
Get full text

Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients by Frangos, Savvas, Iakovou, Ioannis P., Marlowe, Robert J., Eftychiou, Nicolaos, Patsali, Loukia, Vanezi, Anna, Savva, Androulla, Mpalaris, Vassilis, Giannoula, Evanthia I.

“…Purpose Typically formulated by investigators from “world centres of excellence,” differentiated thyroid carcinoma (DTC) management guidelines may have more…”
Get full text

Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study by Frangos, Savvas, Iakovou, Ioannis P., Marlowe, Robert J., Eftychiou, Nicolaos, Patsali, Loukia, Vanezi, Anna, Savva, Androulla, Mpalaris, Vassilis, Giannoula, Evanthia I.

“…Purpose We determined the reasons for radioiodine thyroid remnant ablation, and the procedure’s necessity based on postsurgical remnant size, in patients with…”
Get full text

Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type by Grolimund, Eva, Kutz, Alexander, Marlowe, Robert J, Vögeli, Alaadin, Alan, Murat, Christ-Crain, Mirjam, Thomann, Robert, Falconnier, Claudine, Hoess, Claus, Henzen, Christoph, Zimmerli, Werner, Mueller, Beat, Schuetz, Philipp

“…Long-term outcome prediction in COPD is challenging. We conducted a prospective 5-7-year follow-up study in patients with COPD to determine the association of…”
Get more information

No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer by Verburg, Frederik Anton, Stokkel, Marcel P M, Düren, Christian, Verkooijen, Robbert B T, Mäder, Uwe, van Isselt, Johannes W, Marlowe, Robert J, Smit, Johannes W, Reiners, Christoph, Luster, Markus

“…To compare disease-specific survival and recurrence-free survival (RFS) after successful (131)I ablation in patients with differentiated thyroid carcinoma…”
Get full text

Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18 F-FDG versus 68 Ga-DOTATOC in hepatic NET metastasis by Sänger, Philipp, Schierz, Jan-Henning, Marlowe, Robert J, Freesmeyer, Martin

Get full text